EGR1 and ischemic stroke: PPARG plays an important role in the inflammatory response after ischemic stroke and can target EGR-1 to inhibit the inflammatory response after ischemic stroke [60], and its activation inhibition can increase M2 and decrease M1 microglia/macrophage [61, 62].